| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $5.20B | -2.7% |
| Cost of Revenue | $3.46B | -3.1% |
| Gross Profit | $1.73B | -2.1% |
| R&D Expense | $103.4M | +10.5% |
| SG&A Expense | $681.4M | -6.7% |
| Operating Income | $1.04B | +0.6% |
| Interest Expense | $40.9M | +5.7% |
| Pre-tax Income | $996.8M | +0.3% |
| Income Tax | $191.0M |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $34.2M | -91.8% |
| Short-term Investments | $500K | -93.1% |
| Accounts Receivable | $578.8M | -12.4% |
| Inventory | $1.15B | +63.5% |
| Current Assets | $1.90B | +1.0% |
| Total Assets | $4.08B | +17.6% |
| Current Liabilities | $1.19B | -9.3% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $757.6M | -19.9% |
| Capital Expenditures | $118.8M | -27.4% |
| Investing Cash Flow | -$655.6M | -275.9% |
| Financing Cash Flow | -$465.7M | -11.3% |
| Free Cash Flow | $638.8M | -18.3% |
| +2.2% |
| Net Income | $805.8M | -0.1% |
| EPS (Basic) | $22.89 | +1.0% |
| EPS (Diluted) | $22.79 | +1.1% |
| Long-term Debt |
| $1.14B |
| +37.3% |
| Total Liabilities | $2.92B | +11.3% |
| Stockholders' Equity | $1.16B | +36.8% |